Protein phosphatase 2A (PP2A), a tumor suppressor, is downregulated in many malignancies [7,8], including NB [9,10], and the MYCN proto-oncogene is a well-characterized PP2A substrate [11]. The gene discussed is MYCN; the disease is neuroblastoma.